sALCL

May 18, 2020May 18, 2020

Adcetris Plus Chemo Now First-line Treatment of Adults with sALCL in Europe

News

The European Commission (EC) has approved Adcetris (brentuximab vedotin) when used alongside chemotherapy as a first treatment for adults with systemic anaplastic large cell lymphoma (sALCL), a type of peripheral T-cell ... Read more

September 11, 2017September 11, 2017

Advisory Agency Decision Will Make Lymphoma Therapy Adcetris More Accessible in UK

News

Britain’s national health service advisory agency has made a decision that will make Adcetris (brentuximab vedotin) more accessible as a treatment for an aggressive type of lymphoma. The National Institute for Health and ... Read more

April 8, 2016April 8, 2016

Patient-reported Outcomes in Lymphoma Clinical Trials Are Recognized as Important Tools

News

Patient-reported outcomes in clinical trials of brentuximab vedotin for Hodgkin lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) show improvements in patients’ health-related quality of life, emphasizing their importance for patient management ... Read more